Browsing by Author Gebski, Val

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 198  next >
Issue DateTitleAuthor(s)Citation
2014Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)Boland, Amy; Chatfield, Mark; Gebski, Val; Grimison, Peter; Houghton, Baerin; Stockler, Martin; et al, Various; Friedlander, Michael; Gruney, H; Kichenadasse, G; Lewis, Craig; Rosenthal, M; Singhal, N; Thomson, D B; Toner, Guy C.; Vasey, P; Wong, S; Northern Clinical School: Medicine; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAccelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Annals of Oncology, vol.25, 1, 2014,pp 143-148
2005Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck.Gebski, Val; Veness, Michael; Morgan, Graeme William; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck., Head & Neck: journal for the sciences and specialities of the head and neck, vol.27,(3),2005,pp 208-216
2005Allocation concealment and blinding [reply]Forder, Peta; Gebski, Val; Keech, Anthony (Tony); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAllocation concealment and blinding [reply], Medical Journal of Australia, vol.183,(3),2005,pp 165-166
2005Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?Gebski, Val; Morgan, Gary; Veness, Michael; Sathiyaseelan, Y; School of Public Health: NH&MRC Clinical Trials Centre; Education Faculty Admin; Western Clinical School: Medicine (Westmead)Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?, ANZ Journal of Surgery 2005, vol.75,(3),2005,pp 101-105
2003Anterior tongue cancer: age is not a predictor of outcome and should not alter treatmentGebski, Val; Veness, Michael; Morgan, Gary J.; Sathiyaseelan, Yasoda; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment, ANZ Journal of Surgery, vol.73,(11),2003,pp 899-904
2008Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinomaDhillon, Haryana; Gebski, Val; Hargreaves, Carol; Nowak, Anna; Stockler, Martin; Cebon, Jonathon; Findlay, Michael; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, vol.4, N/A, 2008,pp 55-67
2003Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancerBerry, Martin; Cakir, Burcu; Gebski, Val; Kneebone, Andrew; Turner, Sandra L.; Medical Radiation Sciences; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAustralian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer, Australasian Radiology, vol.47,(4),2003,pp 422-427
2008Basal cell carcinoma of the nose: An Australian and New Zealand Radiation Oncology patterns-of practice studyGebski, Val; Veness, Michael; Chong, L; Tiver, K; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Basal cell carcinoma of the nose: An Australian and New Zealand Radiation Oncology patterns-of practice study, Journal of Medical Imaging and Radiation Oncology, vol.52, N/A, 2008,pp 382-393
2017Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trialDavies, Lucy; Gebski, Val; Gibbs, Emma; Lee, C.; Veillard, Anne-Sophie; Bamias, A; Bloemendal, H; Dimopoulos, M; Floquet, A.; Kosse, J; Lykka, M; Mirza, Mansoor Raza; Pujade-Lauraine, Eric; santaballa, A; Tabaro, G; Vergote, I; Zagouri, F; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trial, Annals of Oncology, vol.28, 8, 2017,pp 1842-1848
2004Book Review: Statistics in Clinical OncologyGebski, Val; School of Public Health: NH&MRC Clinical Trials CentreBook Review: Statistics in Clinical Oncology, Statistics in Medicine, vol.23,(13),2004,pp 2151-2153
2006The bottom line: outcomes after conservation treatment in anal cancer.Gebski, Val; Dwyer, M. K.; Jayamohan, Jay; School of Public Health: NH&MRC Clinical Trials CentreThe bottom line: outcomes after conservation treatment in anal cancer., Australasian Radiology (2005), vol.50,(1),2006,pp 46-51
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2010Capecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study.Gebski, Val; Simes, Robert John; Stockler, Martin; Zannino, Diana; Ackland, Stephen P.; Broad, Adam; Chua, Yu Jo; Cummins, Michelle; Cunningham, David; Forgeson, Garry; Ganju, Vinod; Price, Timothy; Robinson, Bridget; Saunders, M; Tebbutt, Niall C; van Hazel, Guy; Wilson, Kate; Zalcberg, J; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCapecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study., Journal of Clinical Oncology (Online), vol.28, 19,pp 3191-3198
2011Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancerBrown, Christopher; Gebski, Val; Gurney, Howard; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Bacon, M; Donadello, Nicoletta; Friedlander, Michael; Maenpaa, J; Meier, W; Petru, E; Pujade-Lauraine, Eric; Reed, N; Sorio, R; Tulunay, G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCarboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer, British Journal of Cancer, vol.105, 3, 2011,pp 360-365
2017Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trialCanfell, Karen; Farnsworth, Annabelle; Gebski, Val; Brotherton, Julia; Caruana, Michael; Castle, Philip E; Darlington-Brown, Jessica; Gertig, Dorota; Heley, Stella; Jennett, Chloe; Saville, Marion; Tan, Jeffrey; Wrede, C; School of Public Health: Public Health; School of Public Health: Public Health; NH&MRC Clinical Trials CentreCervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial, PLoS Medicine, vol.14, 9, 2017,pp 1-21
2014Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular diseaseCaterson, Ian; Espinoza, David; Gebski, Val; Ivers, Lucy; Seimon, Radhika; Coutinho, Walmir; Finer, N; James, W; Legler, U F; Sharma, Arya; Boden Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Boden InstituteChanges in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease, International Journal of Obesity, vol.38, 9, 2014,pp 1165-1171
2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trialCaterson, Ian; Espinoza, David; Gebski, Val; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U F; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Boden Institute; Boden InstituteChanges in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial, International Journal of Obesity, vol.39, 5, 2015,pp 849-857
2002Changes in stress perceptions of radiation therapists following a debriefing programBeldham-Collins, Rachael; Gebski, Val; Lewis, Jillian; Medical Radiation Sciences; School of Public Health: NH&MRC Clinical Trials CentreChanges in stress perceptions of radiation therapists following a debriefing program, Radiographer, vol.49,(3),2002,pp 133-135
2017Checkpoint Inhibitors in Metastatic EGFR-Mutated Non`Small Cell Lung Cancer A Meta-AnalysisGebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Links, Matthew; Man, J; Mok, Tony; Yang, J; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreCheckpoint Inhibitors in Metastatic EGFR-Mutated Non`Small Cell Lung Cancer A Meta-Analysis, Journal of Thoracic Oncology, vol.12, 2, 2017,pp 403-407
2017Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)Gebski, Val; Gibbs, Emma; Lindemann, Kristina; Auranen, Annika; Avall-Lundqvist, Elisabeth; dePont Christensen, Rene; Dorum, Anne; Grenman, Seija; Hjerpe, Elisabet; Hoegberg, Thomas; Kalling, Marten; Kristensen, G; Rosenberg, Per; Skeie-Jensen, Tone; Woie, Kathrine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreChemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist), British Journal of Cancer, vol.116, 4, 2017,pp 455-463